CHITOGENX REPORTS FIRST QUARTER 2024 RESULTS
Patient recruitment for our Rotator cuff repair Phase I/II trial reached important milestone ORTHO-R soft-tissue residency properties confirmed in...
Source: newswire.ca
Frederic Dumais News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Frederic Dumais. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Frederic Dumais Today - Breaking & Trending Today
CHITOGENX REPORTS 2023 FISCAL YEAR-END RESULTS
Successful completion of initial portion of U.S. Phase I/II ORTHO-R rotator cuff tear repair clinical trial Phil Deschamps and Jonathan Sackier M.D. hired as...
Source: newswire.ca
Valeo Pharma to Webcast Live at VirtualInvestorConferences.com March 9th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on…
Source: financialpost.com
CHITOGENX REPORTS ITS THIRD QUARTER 2023 RESULTS
Successful completion of initial portion of U.S. Phase I/II ORTHO-R rotator cuff tear repair clinical trial Balance sheet restructured with $5.8 million...
Source: newswire.ca
VALEO PHARMA REPORTS RECORD THIRD QUARTER 2022 RESULTS AND HIGHLIGHTS
/CNW Telbec/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today reported its...
Source: newswire.ca